PureTech Health plc (PRTC) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
PRTC Revenue Analysis (2013–2024)
As of March 1, 2026, PureTech Health plc (PRTC) generated trailing twelve-month (TTM) revenue of $6.3 million, reflecting explosive growth of +542.7% year-over-year. The most recent quarter (Q2 2025) recorded $1.9 million in revenue, down 54.0% sequentially.
Looking at the longer-term picture, PRTC's 5-year compound annual growth rate (CAGR) stands at -11.1%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $16.4 million in 2018.
When compared to Healthcare sector peers including REGN (+1.0% YoY), IMNM (-4.4% YoY), and CLDX (-78.6% YoY), PRTC has outperformed the peer group in terms of revenue growth. Compare PRTC vs REGN →
Peer Comparison
Compare PRTC's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PRTCCurrent | $6M | +542.7% | -11.1% | -2818.9% | |
| REGN | $14.3B | +1.0% | +11.0% | 25.7% | |
| IMNM | $9M | -4.4% | - | -3382.4% | |
| CLDX | $2M | -78.6% | -27.4% | -19160.0% | |
| RXRX | $75M | +27.5% | +85.4% | -867.9% | |
| NRIX | $84M | +54.0% | +36.3% | -340.2% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $4.8M | +45.0% | $1.3M | 26.0% | $-136,095,000 | -2818.9% |
| 2023 | $3.3M | +59.3% | $-1,603,000 | -48.1% | $-146,199,000 | -4390.4% |
| 2022 | $2.1M | -79.1% | $-136,815,000 | -6546.2% | $-197,807,000 | -9464.4% |
| 2021 | $10.0M | +19.6% | $-100,492,000 | -1007.0% | $-150,282,000 | -1506.0% |
| 2020 | $8.3M | -4.0% | $8.3M | 100.0% | $-119,531,000 | -1433.1% |
| 2019 | $8.7M | -46.9% | $-77,160,000 | -888.1% | $-135,399,000 | -1558.5% |
| 2018 | $16.4M | +2418.6% | $-61,031,000 | -372.8% | $-104,019,000 | -635.4% |
| 2017 | $650K | -85.3% | $-70,385,000 | -10828.5% | $-115,420,000 | -17756.9% |
| 2016 | $4.4M | -62.3% | $2.9M | 64.6% | $-73,929,000 | -1668.4% |
| 2015 | $11.7M | +483.5% | $11.0M | 93.7% | $-43,642,000 | -371.7% |
See PRTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRTC Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare PRTC vs AGIO
See how PRTC stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is PRTC's revenue growth accelerating or slowing?
PRTC revenue is accelerating at +542.7% year-over-year, exceeding the 5-year CAGR of -11.1%. TTM revenue reached $6M. Growth momentum has increased versus prior periods.
What is PRTC's long-term revenue growth rate?
PureTech Health plc's 5-year revenue CAGR of -11.1% reflects the sustained expansion pattern. Current YoY growth of +542.7% is above this long-term average.
How is PRTC's revenue distributed by segment?
PRTC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.